Min Yi, Ph.D. - Publications

Affiliations: 
2011 Biostatistics The University of Texas School of Public Health 
Area:
Biostatistics Biology, Oncology

50 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Karakas C, Francis AM, Ha MJ, Wingate HF, Meena RA, Yi M, Rasaputra KS, Barrera AMG, Arun B, Do KA, Sahin A, Keyomarsi K, Hunt KK. Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer. Annals of Surgery. PMID 31436549 DOI: 10.1097/SLA.0000000000003551  0.44
2019 Kettner NM, Vijayaraghavan S, Durak MG, Bui T, Kohansal M, Ha MJ, Liu B, Rao X, Wang J, Yi M, Carey JP, Chen X, Eckols TK, Raghavendra AS, Ibrahim NK, et al. Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30867218 DOI: 10.1158/1078-0432.CCR-18-3274  0.44
2019 Park KU, Kyrish K, Terrell J, Yi M, Caudle AS, Hunt KK, Kuerer HM, Bedrosian I, Thompson A, DeSnyder SM. Surgeon perception versus reality: Opioid use after breast cancer surgery. Journal of Surgical Oncology. PMID 30737785 DOI: 10.1002/jso.25395  0.44
2018 Chen X, Low KH, Alexander A, Jiang Y, Karakas C, Hess KR, Carey JP, Bui T, Vijayaraghavan S, Evans KW, Yi M, Ellis DC, Cheung KL, Ellis IO, Fu S, et al. Cyclin E overexpression sensitizes triple negative breast cancer to Wee1 kinase Inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30181387 DOI: 10.1158/1078-0432.CCR-18-1446  0.44
2017 Weiss A, Chavez-MacGregor M, Lichtensztajn DY, Yi M, Tadros A, Hortobagyi GN, Giordano SH, Hunt KK, Mittendorf EA. Validation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast Cancer. Jama Oncology. PMID 29222540 DOI: 10.1001/jamaoncol.2017.4298  0.44
2017 Mittendorf EA, Chavez-MacGregor M, Vila J, Yi M, Lichtensztajn DY, Clarke CA, Giordano SH, Hunt KK. Bioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology. Annals of Surgical Oncology. PMID 28726077 DOI: 10.1245/s10434-017-6009-x  0.44
2017 Vijayaraghavan S, Karakas C, Doostan I, Chen X, Bui T, Yi M, Raghavendra AS, Zhao Y, Bashour SI, Ibrahim NK, Karuturi M, Wang J, Winkler JD, Amaravadi RK, Hunt KK, et al. CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers. Nature Communications. 8: 15916. PMID 28653662 DOI: 10.1038/ncomms15916  0.44
2017 Akay CL, Albarracin C, Torstenson T, Bassett R, Mittendorf EA, Yi M, Kuerer HM, Babiera GV, Bedrosian I, Hunt KK, Hwang RF. Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer. The Breast Journal. PMID 28608612 DOI: 10.1111/tbj.12829  0.44
2017 Alexander A, Karakas C, Chen X, Carey JP, Yi M, Bondy M, Thompson P, Cheung KL, Ellis IO, Gong Y, Krishnamurthy S, Alvarez RH, Ueno NT, Hunt KK, Keyomarsi K. Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer. Oncotarget. PMID 28107181 DOI: 10.18632/oncotarget.14689  0.44
2016 Hunt KK, Karakas C, Ha MJ, Biernacka A, Yi M, Sahin A, Adjapong O, Hortobogyi GN, Bondy ML, Thompson PA, Cheung KL, Ellis IO, Bacus S, Symmans WF, Do KA, et al. Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27881578 DOI: 10.1158/1078-0432.CCR-16-2217  0.44
2016 FitzSullivan E, Bassett RL, Kuerer HM, Mittendorf EA, Yi M, Hunt KK, Babiera GV, Caudle AS, Black DM, Bedrosian I, Reyna C, Teshome M, Meric-Bernstam F, Hwang R. Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy. Annals of Surgical Oncology. PMID 27822630 DOI: 10.1245/s10434-016-5605-5  0.44
2016 Carter SA, Lyons GR, Kuerer HM, Bassett RL, Oates S, Thompson A, Caudle AS, Mittendorf EA, Bedrosian I, Lucci A, DeSnyder SM, Babiera G, Yi M, Baumann DP, Clemens MW, et al. Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction. Annals of Surgical Oncology. PMID 27406093 DOI: 10.1245/s10434-016-5407-9  0.44
2016 Yi M, Hunt KK. Organizing a breast cancer database: data management. Chinese Clinical Oncology. PMID 27197511 DOI: 10.21037/cco.2016.04.04  0.44
2016 Karakas C, Biernacka A, Bui T, Sahin A, Yi M, Akli S, Schafer J, Alexander A, Adjapong O, Hunt KK, Keyomarsi K. Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer. The American Journal of Pathology. PMID 27182644 DOI: 10.1016/j.ajpath.2016.02.024  0.44
2015 Yi M, Hunt KK. Optimizing Mammography Screening Intervals. Jama. 314: 1635-6. PMID 26501538 DOI: 10.1001/jama.2015.13149  0.44
2015 Caruso JA, Karakas C, Zhang J, Yi M, Albarracin C, Sahin A, Bondy M, Liu J, Hunt KK, Keyomarsi K. Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence. Breast Cancer Research : Bcr. 17: 87. PMID 26108797 DOI: 10.1186/s13058-015-0572-5  0.44
2015 Francis AM, Haugen CE, Grimes LM, Crow JR, Yi M, Mittendorf EA, Bedrosian I, Caudle AS, Babiera GV, Krishnamurthy S, Kuerer HM, Hunt KK. Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ? Annals of Surgical Oncology. PMID 25905585 DOI: 10.1245/s10434-015-4547-7  0.44
2015 Luo S, Su X, Yi M, Hunt KK. Simultaneous inference of a misclassified outcome and competing risks failure time data. Journal of Applied Statistics. 42: 1080-1090. PMID 25821331 DOI: 10.1080/02664763.2014.995606  0.44
2015 Mittendorf EA, Ballman KV, McCall LM, Yi M, Sahin AA, Bedrosian I, Hansen N, Gabram S, Hurd T, Giuliano AE, Hunt KK. Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 1119-27. PMID 25488970 DOI: 10.1200/JCO.2014.57.2958  0.44
2015 Rueth NM, Black DM, Limmer AR, Gabriel E, Huo L, Fornage BD, Dogan BE, Chavez-MacGregor M, Yi M, Hunt KK, Strom EA. Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer. Annals of Surgical Oncology. 22: 90-5. PMID 25249256 DOI: 10.1245/s10434-014-3991-0  0.44
2014 Caruso JA, Karakas C, Zhang J, Yi M, Albarracin C, Sahin A, Bondy M, Liu J, Hunt KK, Keyomarsi K. Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence. Breast Cancer Research : Bcr. 16: 3417. PMID 25551582 DOI: 10.1186/s13058-014-0497-4  0.44
2014 Ren Y, Black DM, Mittendorf EA, Liu P, Li X, Du XL, He J, Yang J, Hunt KK, Yi M. Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race. Plos One. 9: e110281. PMID 25333877 DOI: 10.1371/journal.pone.0110281  0.44
2014 Caudle AS, Kuerer HM, Le-Petross HT, Yang W, Yi M, Bedrosian I, Krishnamurthy S, Fornage BD, Hunt KK, Mittendorf EA. Predicting the extent of nodal disease in early-stage breast cancer. Annals of Surgical Oncology. 21: 3440-7. PMID 24859939 DOI: 10.1245/s10434-014-3813-4  0.44
2014 Bednarski BK, Araujo DM, Yi M, Torres KE, Lazar A, Trent JC, Cormier JN, Pisters PW, Lev DC, Pollock RE, Feig BW, Hunt KK. Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors. Annals of Surgical Oncology. 21: 2499-505. PMID 24639192 DOI: 10.1245/s10434-014-3632-7  0.44
2014 Wang J, Mittendorf EA, Sahin AA, Yi M, Caudle A, Hunt KK, Wu Y. Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database. Plos One. 9: e89778. PMID 24587029 DOI: 10.1371/journal.pone.0089778  0.44
2014 Luo S, Su X, DeSantis SM, Huang X, Yi M, Hunt KK. Joint model for a diagnostic test without a gold standard in the presence of a dependent terminal event. Statistics in Medicine. 33: 2554-66. PMID 24473943 DOI: 10.1002/sim.6101  0.44
2014 Caudle AS, Yi M, Hoffman KE, Mittendorf EA, Babiera GV, Hwang RF, Meric-Bernstam F, Sahin AA, Hunt KK. Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients. Annals of Surgical Oncology. 21: 60-5. PMID 24046126 DOI: 10.1245/s10434-013-3276-z  0.44
2013 Duong MT, Akli S, Macalou S, Biernacka A, Debeb BG, Yi M, Hunt KK, Keyomarsi K. Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells. Cancer Research. 73: 5556-68. PMID 23955388 DOI: 10.1158/0008-5472.CAN-13-0013  0.44
2013 Hunt KK, Wingate H, Yokota T, Liu Y, Mills GB, Zhang F, Fang B, Su CH, Zhang M, Yi M, Keyomarsi K. Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer. Breast Cancer Research : Bcr. 15: R3. PMID 23320734 DOI: 10.1186/bcr3374  0.44
2013 Mittendorf EA, Buchholz TA, Tucker SL, Meric-Bernstam F, Kuerer HM, Gonzalez-Angulo AM, Bedrosian I, Babiera GV, Hoffman K, Yi M, Ross MI, Hortobagyi GN, Hunt KK. Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy. Annals of Surgery. 257: 173-9. PMID 23291658 DOI: 10.1097/SLA.0b013e3182805c4a  0.44
2013 Yi M, Cormier JN, Xing Y, Giordano SH, Chai C, Meric-Bernstam F, Vlastos G, Kuerer HM, Mirza NQ, Buchholz TA, Hunt KK. Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy. Annals of Surgical Oncology. 20: 1514-21. PMID 23224829 DOI: 10.1245/s10434-012-2774-8  0.44
2013 Torres KE, Ravi V, Kin K, Yi M, Guadagnolo BA, May CD, Arun BK, Hunt KK, Lam R, Lahat G, Hoffman A, Cormier JN, Feig BW, Lazar AJ, Lev D, et al. Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer. Annals of Surgical Oncology. 20: 1267-74. PMID 23224828 DOI: 10.1245/s10434-012-2755-y  0.44
2013 Yi M, Kuerer HM, Mittendorf EA, Hwang RF, Caudle AS, Bedrosian I, Meric-Bernstam F, Wagner JL, Hunt KK. Impact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population. Journal of the American College of Surgeons. 216: 105-13. PMID 23122536 DOI: 10.1016/j.jamcollsurg.2012.09.005  0.44
2013 Luo S, Yi M, Huang X, Hunt KK. A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer. Statistics in Medicine. 32: 2320-34. PMID 22996169 DOI: 10.1002/sim.5629  0.44
2012 Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf EA, Bedrosian I, Hwang RF, Caudle AS, Babiera GV, Akins JS, Kuerer HM, Hunt KK. The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Annals of Surgical Oncology. 19: 3177-84. PMID 22772869 DOI: 10.1245/s10434-012-2484-2  0.44
2012 Kong AL, Tereffe W, Hunt KK, Yi M, Kang T, Weatherspoon K, Mittendorf EA, Bedrosian I, Hwang RF, Babiera GV, Buchholz TA, Meric-Bernstam F. Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer. Cancer. 118: 6287-96. PMID 22648744 DOI: 10.1002/cncr.27564  0.44
2012 Duong MT, Akli S, Wei C, Wingate HF, Liu W, Lu Y, Yi M, Mills GB, Hunt KK, Keyomarsi K. LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients. Plos Genetics. 8: e1002538. PMID 22479189 DOI: 10.1371/journal.pgen.1002538  0.44
2012 Yi M, Liu P, Li X, Mittendorf EA, He J, Ren Y, Nayeemuddin K, Hunt KK. Comparative analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States. Cancer. 118: 4117-25. PMID 22460701 DOI: 10.1002/cncr.27399  0.44
2012 Yi M, Meric-Bernstam F, Kuerer HM, Mittendorf EA, Bedrosian I, Lucci A, Hwang RF, Crow JR, Luo S, Hunt KK. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 600-7. PMID 22253459 DOI: 10.1200/JCO.2011.36.4976  0.44
2012 Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, Yi M, Meric-Bernstam F, Ross MI, Babiera GV, Kuerer HM, Hwang RF. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Annals of Surgery. 255: 109-15. PMID 22167004 DOI: 10.1097/SLA.0b013e318238f461  0.44
2011 Yi M, Mittendorf EA, Cormier JN, Buchholz TA, Bilimoria K, Sahin AA, Hortobagyi GN, Gonzalez-Angulo AM, Luo S, Buzdar AU, Crow JR, Kuerer HM, Hunt KK. Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4654-61. PMID 22084362 DOI: 10.1200/JCO.2011.38.3174  0.44
2011 Yi M, Buchholz TA, Meric-Bernstam F, Bedrosian I, Hwang RF, Ross MI, Kuerer HM, Luo S, Gonzalez-Angulo AM, Buzdar AU, Symmans WF, Feig BW, Lucci A, Huang EH, Hunt KK. Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Annals of Surgery. 253: 572-9. PMID 21209588 DOI: 10.1097/SLA.0b013e318208fc2a  0.44
2011 Yi M, Kronowitz SJ, Meric-Bernstam F, Feig BW, Symmans WF, Lucci A, Ross MI, Babiera GV, Kuerer HM, Hunt KK. Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy. Cancer. 117: 916-24. PMID 20945319 DOI: 10.1002/cncr.25505  0.44
2010 Valero V, Kong AL, Hunt KK, Yi M, Hwang RF, Meric-Bernstam F, Bedrosian I, Ross MI, Babiera GV, Litton JK, Mittendorf EA. Sentinel lymph node dissection is technically feasible in older breast cancer patients. Clinical Breast Cancer. 10: 477-82. PMID 21147692 DOI: 10.3816/CBC.2010.n.063  0.44
2010 Yi M, Giordano SH, Meric-Bernstam F, Mittendorf EA, Kuerer HM, Hwang RF, Bedrosian I, Rourke L, Hunt KK. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Annals of Surgical Oncology. 17: 343-51. PMID 20853057 DOI: 10.1245/s10434-010-1253-3  0.44
2010 Kang T, Yi M, Hunt KK, Mittendorf EA, Babiera GV, Kuerer H, Bedrosian I, Hwang RF, Lucci A, Meric-Bernstam F. Does blue dye contribute to success of sentinel node mapping for breast cancer? Annals of Surgical Oncology. 17: 280-5. PMID 20853047 DOI: 10.1245/s10434-010-1235-5  0.44
2010 Yi M, Hunt KK, Arun BK, Bedrosian I, Barrera AG, Do KA, Kuerer HM, Babiera GV, Mittendorf EA, Ready K, Litton J, Meric-Bernstam F. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prevention Research (Philadelphia, Pa.). 3: 1026-34. PMID 20647335 DOI: 10.1158/1940-6207.CAPR-09-0130  0.44
2009 Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera GV, Bedrosian I, Hwang RF, Kuerer HM, Ross MI, Meric-Bernstam F. Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Annals of Surgery. 250: 558-66. PMID 19730235 DOI: 10.1097/SLA.0b013e3181b8fd5e  0.44
2009 Yi M, Meric-Bernstam F, Middleton LP, Arun BK, Bedrosian I, Babiera GV, Hwang RF, Kuerer HM, Yang W, Hunt KK. Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer. 115: 962-71. PMID 19172584 DOI: 10.1002/cncr.24129  0.44
2008 Mittendorf EA, Sahin AA, Tucker SL, Meric-Bernstam F, Yi M, Nayeemuddin KM, Babiera GV, Ross MI, Feig BW, Kuerer HM, Hunt KK. Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Annals of Surgical Oncology. 15: 3369-77. PMID 18815841 DOI: 10.1245/s10434-008-0153-2  0.44
Show low-probability matches.